Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

PLoS One 2017 27;12(2):e0169962. Epub 2017 Feb 27.

Department of Surgery, Institut Curie, Paris, France.

Background: Avoiding axillary lymph node dissection (ALND) for invasive breast cancers with isolated tumor cells or micrometastatic sentinel node biopsy (SNB) could decrease morbidity with minimal clinical significance.

Purpose: The aim of this study is to simulate the medico-economic impact of the routine use of the MSKCC non-sentinel node (NSN) prediction nomogram for ER+ HER2- breast cancer patients.

Methods: We studied 1036 ER+ HER2- breast cancer patients with a metastatic SNB. All had a complementary ALND. For each patient, we calculated the probability of the NSN positivity using the MSKCC nomogram. After validation of this nomogram in the population, we described how the patients' characteristics spread as the threshold value changed. Then, we performed an economic simulation study to estimate the total cost of caring for patients treated according to the MSKCC predictive nomogram results.

Results: A 0.3 threshold discriminate the type of sentinel node (SN) metastases: 98.8% of patients with pN0(i+) and 91.6% of patients with pN1(mic) had a MSKCC score under 0.3 (false negative rate = 6.4%). If we use the 0.3 threshold for economic simulation, 43% of ALND could be avoided, reducing the costs of caring by 1 051 980 EUROS among the 1036 patients.

Conclusion: We demonstrated the cost-effectiveness of using the MSKCC NSN prediction nomogram by avoiding ALND for the pN0(i+) or pN1(mic) ER+ HER2- breast cancer patients with a MSKCC score of less than or equal to 0.3.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169962PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328272PMC
September 2017
43 Reads

Publication Analysis

Top Keywords

her2- breast
12
er+ her2-
12
breast cancer
12
prediction nomogram
12
breast cancers
8
economic simulation
8
sentinel node
8
cancer patients
8
mskcc score
8
nsn prediction
8
non-sentinel node
8
medico-economic impact
8
mskcc non-sentinel
8
mskcc
7
nomogram
6
patients
5
breast
5
node
5
simulation study
4
study estimate
4

References

(Supplied by CrossRef)
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
HJ Burstein et al.
2005
Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. The British journal of surgery
C Nos et al.
England 2003
An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement
E Barranger et al.
2005
Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer
RF Saidi et al.
The American surgeon 2004
The prognostic significance of axillary lymph-node micrometastases in breast cancer patients
GP Kuijt et al.
European Journal of Surgical Oncology (EJSO) 2005
Axillary Recurrence Rate in Breast Cancer Patients With Negative Sentinel Lymph Node (SLN) or SLN
I Langer et al.
2005

Similar Publications